Trial intelligence / Profile preview

Articaine and Lidocaine in Extraction of Wisdom Teeth

NCT05804630Unknown

Sponsor
National Taiwan University Hospital
Start
Mar 2023
Primary completion
Jan 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of articaine and lidocaine in impacted third molar (I3M) (4 arms), sponsored by National Taiwan University Hospital. Primary endpoints: Hemodynamic measures, O2 saturation and 1 more. Status: unknown.

02

Drugs

articainelidocaine
03

Conditions

impacted third molar (I3M)

Beyond the preview

Go deeper on NCT05804630.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05804630.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call